Annual report pursuant to Section 13 and 15(d)

Other Income / (Expense)

v3.24.2.u1
Other Income / (Expense)
12 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Other Income / (Expense)

Note 11. Other Income / (Expense)

The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows (in thousands):

Year Ended June 30, 

    

2024

    

2023

    

2022

Interest expense

$

(15,736)

$

(11,215)

$

(11,309)

Interest income

3,323

3,410

794

Gain (loss) on investment(1)

283

49,328

15,186

Gain (loss) on equity method investment

(6,841)

(1,143)

Other non-operating income (expense), net

 

(2,026)

 

(665)

 

125

Total other income (expense)

$

(20,997)

$

39,715

$

4,796

(1) For the year ended June 30, 2024, this is for a $0.3 million gain on the sale of our exchange trade investment grade bond funds. For the year ended June 30, 2023, this is for a $37.2 million gain on the sale of our CCXI investment, a $11.7 million gain on the sale of Eminence, and a gain of $0.4 million related to the change in fair value of our exchange traded bond funds. For the year ended June 30, 2022, this is for a $16.1 million gain in the fair value of our CCXI investment.